A Randomised Phase 2 Study of Neoadjuvant Docetaxel and Cyclophosphamide Compared to Doxorubicin and Cyclophosphamide in Operable Node Negative Breast Cancer With Normal Topoisomerase II alpha Expression.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Docetaxel (Primary) ; Cyclophosphamide; Doxorubicin
- Indications Breast cancer
- Focus Therapeutic Use
- 08 Dec 2008 New trial record.